Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Osteoporosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43874   clinical trials with a EudraCT protocol, of which   7294   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    303 result(s) found for: Osteoporosis. Displaying page 1 of 16.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-013935-39 Sponsor Protocol Number: CL3-06911-002 Start Date*: 2009-12-28
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopau...
    Medical condition: Osteoporotic men and postmenauposal women
    Disease: Version SOC Term Classification Code Term Level
    12.0 10031283 Osteoporosis fracture LLT
    12.0 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) ES (Completed) FR (Completed) BE (Completed) GB (Completed) CZ (Completed) DE (Completed) DK (Prematurely Ended) AT (Completed) HU (Completed) PL (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2010-022587-12 Sponsor Protocol Number: VitK Start Date*: 2015-01-20
    Sponsor Name:Guy's and St. Thomas' NHS Foundation Trust
    Full Title: The Additive effect of Vitamin K Supplementation and Bisphosphonate on Fracture Risk in Post-menopausal Osteoporosis
    Medical condition: Post-menopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    20.1 10028395 - Musculoskeletal and connective tissue disorders 10031286 Osteoporosis senile LLT
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10031283 Osteoporosis fracture LLT
    21.0 10028395 - Musculoskeletal and connective tissue disorders 10017082 Fracture due to osteoporosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-001509-11 Sponsor Protocol Number: CL3-12911-030 Start Date*: 2007-10-31
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with p...
    Medical condition: Post-menopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) IT (Completed) DE (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2006-001796-37 Sponsor Protocol Number: ALENDRONATO Start Date*: 2006-06-07
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
    Full Title: Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis
    Medical condition: postmenopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10031285 PT
    Population Age: Elderly Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-002934-34 Sponsor Protocol Number: 2020-AKA Start Date*: 2020-11-04
    Sponsor Name:Aarhus University Hospital, dept. of Diabetes and Hormonal diseases
    Full Title: The effects of melatonin treatment on bone, marrow, sleep and arterial stiffness in postmenopausal women
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-006086-16 Sponsor Protocol Number: CL3-12911-032 Start Date*: 2007-12-06
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of...
    Medical condition: male osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031282 Osteoporosis PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: HU (Completed) BE (Completed) NL (Completed) FR (Completed) SE (Completed) IE (Completed) IT (Completed) ES (Completed) DE (Completed) PL (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-002958-29 Sponsor Protocol Number: TERIPARATIDE Start Date*: 2006-08-02
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
    Full Title: STUDY OF CIRCULATING OSTEOBLAST-LINEAGE CELLS IN RELATION WITH TERIPARATIDE THERAPY.
    Medical condition: post-menopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10031285 PT
    Population Age: Elderly Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000715-29 Sponsor Protocol Number: SR-SJI/AM Start Date*: 2007-04-16
    Sponsor Name:University Hospitals of Leicester - Research & Development
    Full Title: Serum and urinary strontium levels and possible interference with measurement of other minerals in subjects taking Strontium ranelate (Protelos) for osteoporosis.
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10031282 Osteoporosis PT
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-005618-38 Sponsor Protocol Number: OPG/RANKL/RANK/1 Start Date*: 2007-11-21
    Sponsor Name:U.L.S.S. 9 DI TREVISO
    Full Title: The OPG/RANKL/RANK system: implication for osteoporosis and atherosclerosis development. Potential role of the treatment with Atorvastatin
    Medical condition: Osteoporosis in hypercholesterolemic patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031282 Osteoporosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014270-18 Sponsor Protocol Number: CL3-06911-003 Start Date*: 2010-01-13
    Sponsor Name:Laboratorios Servier S.L.
    Full Title: "Eficacia y seguridad de una administración oral diaria de S06911 (combinación fija de ranelato de estroncio 2g / vitamina D3 1000UI) en la deficiencia de vitamina D para el tratamiento de la osteo...
    Medical condition: Osteoporosis en hombres y mujeres postmenopáusicas
    Disease: Version SOC Term Classification Code Term Level
    9 10031283 Osteoporosis fracture LLT
    9 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) BE (Completed) DK (Prematurely Ended) SK (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2013-001279-19 Sponsor Protocol Number: 20120187 Start Date*: 2014-03-26
    Sponsor Name:Amgen, Inc
    Full Title: A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
    Medical condition: Post Menospausal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    16.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed) PL (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-001865-28 Sponsor Protocol Number: 08/H0802/9 Start Date*: 2008-05-30
    Sponsor Name:King's College London [...]
    1. King's College London
    2. Guys and St Thomas NHS Foundation Trust
    Full Title: The Relationship between Osteoporosis and Aortic Calcification in Postmenopausal Women
    Medical condition: Osteoporosis; Aortic Calcification
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10054208 Aortic calcification PT
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-001511-22 Sponsor Protocol Number: 004 Start Date*: 2005-08-24
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,
    Full Title: A 5-Year Open Label Extension to: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in the Treatment of Postmenopausal W...
    Medical condition: Postmenopausal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) DK (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-000434-35 Sponsor Protocol Number: 20120156 Start Date*: 2013-12-10
    Sponsor Name:Amgen, Inc
    Full Title: A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate the Noninferiority of Romosozumab at a 90 mg/mL Concentration Compared With a 70 mg/mL Concentration in Postmenopausal Women With...
    Medical condition: Postmenopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    16.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: PL (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2007-001671-11 Sponsor Protocol Number: Version 1.1 Start Date*: 2007-09-20
    Sponsor Name:Medizinische Universität Graz
    Full Title: Influence of urinary acidification by l-Methionine on bone metabolism and acid base status
    Medical condition: We will explore the influence of urinary acidification by l-Methionine on bone metabolism and acid base status in order to evaluate whether this treatment could be a potential risk factor for osteo...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031282 Osteoporosis LLT
    Population Age: Adults Gender: Male
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-005581-39 Sponsor Protocol Number: CL3-12911-025 Start Date*: 2007-04-02
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bo...
    Medical condition: Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) FR (Completed) HU (Completed) NL (Completed) CZ (Completed) IT (Completed) DK (Completed) EE (Completed) GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-008257-30 Sponsor Protocol Number: 0822-042 Start Date*: 2009-03-31
    Sponsor Name:Merck & Co., Inc.
    Full Title: Estudio en fase IIa aleatorizado, doble ciego, controlado con placebo para evaluar los efectos de odanacatib (MK-0822) sobre la densidad mineral ósea (DMO) y la seguridad general en el tratamiento ...
    Medical condition: Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed) CZ (Completed) DE (Completed) BE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2005-002780-82 Sponsor Protocol Number: 63513 Start Date*: 2005-07-20
    Sponsor Name:Richter Gedeon Rt
    Full Title: Alendronat (Sedron 70 mg) hatékonyságának és biztonságosságának nyílt, multicentrikus, fázis IV vizsgálata osteoporosisban szenvedő veseköves férfibetegekben
    Medical condition: osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    8.0 10031282 PT
    Population Age: Adults Gender: Male
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-022576-30 Sponsor Protocol Number: BA058-05-003 Start Date*: 2011-02-21
    Sponsor Name:Radius Health, Inc.
    Full Title: A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopau...
    Medical condition: Osteoporosis in postmenopausal women
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10031285 Osteoporosis postmenopausal PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: EE (Completed) LT (Completed) DK (Completed) CZ (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-006065-16 Sponsor Protocol Number: FP-006-IM Start Date*: 2007-03-19
    Sponsor Name:Nycomed Danmark ApS
    Full Title: A 24-week, international, multi centre, randomised, open label, parallel group, phase IV clinical trial investigating changes in bone formation markers in postmenopausal women with primary osteopor...
    Medical condition: Primary postmenopausal osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Completed) ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 17 06:31:13 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA